PREDNISOLONE ORAL

PREDNISOLONE ORAL was reported 182696 times

PREDNISOLONE ORAL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ALVEOLAR PROTEINOSIS 189 0.3193
1 PARVOVIRUS B19 INFECTION 275 0.3073
2 C-REACTIVE PROTEIN 269 0.2902
3 PULMONARY NOCARDIOSIS 238 0.2888
4 DEEP VEIN THROMBOSIS POSTOPERATIVE 550 0.2746
5 STEROID DIABETES 402 0.2678
6 POLYOMAVIRUS VIRAEMIA 264 0.2486
7 HEPATITIS E 389 0.2462
8 STRONGYLOIDIASIS 389 0.2406
9 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 538 0.2294
10 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 153 0.2290
11 PNEUMOCYSTIS JIROVECI PNEUMONIA 510 0.2287
12 MYCOBACTERIUM CHELONAE INFECTION 166 0.2246
13 NOCARDIOSIS 557 0.2176
14 DISSEMINATED CRYPTOCOCCOSIS 150 0.1982
15 CYTOMEGALOVIRUS ENTEROCOLITIS 151 0.1961
16 COMPLICATIONS OF TRANSPLANTED KIDNEY 445 0.1960
17 DELAYED GRAFT FUNCTION 137 0.1927
18 CYTOMEGALOVIRUS COLITIS 443 0.1924
19 VARICELLA ZOSTER VIRUS INFECTION 399 0.1923
20 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 181 0.1911
21 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 972 0.1908
22 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 337 0.1905
23 INFECTION IN AN IMMUNOCOMPROMISED HOST 134 0.1866
24 X-RAY ABNORMAL 330 0.1844
25 INFECTION REACTIVATION 209 0.1825
26 LUPUS VULGARIS 227 0.1802
27 JC VIRUS INFECTION 286 0.1787
28 PNEUMOCYSTIS JIROVECII PNEUMONIA 1781 0.1772
29 LYMPHOPROLIFERATIVE DISORDER 520 0.1769
30 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 206 0.1717
31 CHRONIC ALLOGRAFT NEPHROPATHY 133 0.1699
32 SWOLLEN JOINT COUNT INCREASED 527 0.1651
33 TRANSPLANT REJECTION 1323 0.1650
34 CRYPTOCOCCOSIS 267 0.1637
35 VIRAEMIA 224 0.1616
36 BK VIRUS INFECTION 542 0.1605
37 TRANSPLANT DYSFUNCTION 286 0.1601
38 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 210 0.1595
39 KIDNEY TRANSPLANT REJECTION 759 0.1580
40 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 327 0.1577
41 STEROID DEPENDENCE 138 0.1572
42 CYTOMEGALOVIRUS INFECTION 2607 0.1567
43 PNEUMONIA CYTOMEGALOVIRAL 301 0.1548
44 MENINGITIS CRYPTOCOCCAL 269 0.1537
45 CYTOMEGALOVIRUS TEST POSITIVE 270 0.1513
46 ATYPICAL MYCOBACTERIAL INFECTION 212 0.1498
47 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 495 0.1497
48 LUPUS NEPHRITIS 280 0.1496
49 RHEUMATIC FEVER 663 0.1486
50 FACET JOINT SYNDROME 483 0.1482
51 PNEUMONIA CRYPTOCOCCAL 140 0.1481
52 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 326 0.1477
53 CUSHINGOID 473 0.1472
54 PNEUMOCYSTIS JIROVECII INFECTION 174 0.1456
55 DISLOCATION OF VERTEBRA 332 0.1454
56 EPSTEIN-BARR VIRUS INFECTION 906 0.1449
57 CYTOMEGALOVIRUS CHORIORETINITIS 281 0.1440
58 UPPER RESPIRATORY TRACT INFLAMMATION 171 0.1425
59 BRAIN ABSCESS 355 0.1402
60 SUBCUTANEOUS EMPHYSEMA 136 0.1385
61 HYPOFIBRINOGENAEMIA 137 0.1381
62 CYTOMEGALOVIRUS INFECTION REACTIVATION 610 0.1379
63 RETINITIS 237 0.1371
64 CYTOMEGALOVIRUS VIRAEMIA 609 0.1368
65 LIVER TRANSPLANT REJECTION 245 0.1363
66 EPSTEIN-BARR VIRAEMIA 150 0.1353
67 CHORIORETINOPATHY 190 0.1334
68 MUCORMYCOSIS 347 0.1334
69 BRONCHOPULMONARY ASPERGILLOSIS 1034 0.1332
70 OBLITERATIVE BRONCHIOLITIS 171 0.1302
71 DISSEMINATED TUBERCULOSIS 334 0.1301
72 PNEUMOMEDIASTINUM 235 0.1299
73 HEPATITIS B REACTIVATION 411 0.1294
74 STEROID WITHDRAWAL SYNDROME 132 0.1292
75 SECONDARY IMMUNODEFICIENCY 155 0.1276
76 LISTERIOSIS 139 0.1257
77 DUODENAL ULCER PERFORATION 930 0.1249
78 MYCOBACTERIAL INFECTION 215 0.1247
79 ADENOVIRUS INFECTION 358 0.1233
80 DIFFUSE LARGE B-CELL LYMPHOMA 939 0.1217
81 ASPERGILLUS INFECTION 790 0.1202
82 SYSTEMIC MYCOSIS 140 0.1199
83 PORPHYRIA ACUTE 171 0.1192
84 PERIPHERAL VENOUS DISEASE 479 0.1172
85 HISTIOCYTOSIS HAEMATOPHAGIC 340 0.1144
86 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 810 0.1129
87 C-REACTIVE PROTEIN ABNORMAL 724 0.1128
88 CENTRAL NERVOUS SYSTEM LYMPHOMA 155 0.1124
89 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 251 0.1122
90 RHEUMATOID FACTOR POSITIVE 645 0.1116
91 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 308 0.1113
92 TRANSPLANT FAILURE 268 0.1092
93 ASPERGILLOSIS 140 0.1071
94 PNEUMATOSIS INTESTINALIS 296 0.1037
95 CHRONIC GRAFT VERSUS HOST DISEASE 373 0.1032
96 HEPATITIS B 622 0.1031
97 SYSTEMIC CANDIDA 249 0.0991
98 GRAFT VERSUS HOST DISEASE IN SKIN 217 0.0984
99 HYPOGAMMAGLOBULINAEMIA 646 0.0982
100 HELICOBACTER INFECTION 1000 0.0972
101 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 719 0.0957
102 SYSTEMIC INFECTION 158 0.0952
103 MUSCLE INJURY 779 0.0939
104 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 199 0.0934
105 KLEBSIELLA INFECTION 471 0.0930
106 PULMONARY TUBERCULOSIS 395 0.0924
107 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 762 0.0923
108 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 146 0.0911
109 BACTERIAL SEPSIS 293 0.0899
110 NEUTROPENIC SEPSIS 635 0.0888
111 ENTEROCOCCAL INFECTION 426 0.0881
112 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 571 0.0878
113 INFECTIOUS PLEURAL EFFUSION 131 0.0860
114 FOLLICULITIS 897 0.0855
115 LUNG ABSCESS 179 0.0852
116 THROMBOTIC MICROANGIOPATHY 817 0.0838
117 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 798 0.0835
118 PYODERMA GANGRENOSUM 294 0.0816
119 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 166 0.0813
120 OPPORTUNISTIC INFECTION 148 0.0800
121 PEMPHIGUS 995 0.0795
122 ATYPICAL FEMUR FRACTURE 224 0.0793
123 PYELONEPHRITIS ACUTE 155 0.0790
124 LOW BIRTH WEIGHT BABY 624 0.0785
125 STAPHYLOCOCCAL SEPSIS 386 0.0781
126 PANNICULITIS 188 0.0776
127 PSEUDOMONAS INFECTION 666 0.0776
128 ESCHERICHIA INFECTION 635 0.0771
129 IMMUNOSUPPRESSION 675 0.0764
130 OSTEOPOROTIC FRACTURE 146 0.0762
131 ORGANISING PNEUMONIA 378 0.0762
132 APLASIA PURE RED CELL 258 0.0749
133 LIP DRY 681 0.0749
134 ESCHERICHIA BACTERAEMIA 176 0.0748
135 RHEUMATOID NODULE 206 0.0747
136 LUNG CONSOLIDATION 209 0.0746
137 ACUTE GRAFT VERSUS HOST DISEASE 342 0.0746
138 ARTHRITIS BACTERIAL 306 0.0745
139 SMALL INTESTINAL PERFORATION 138 0.0735
140 HAND DEFORMITY 949 0.0723
141 GRAFT VERSUS HOST DISEASE 515 0.0715
142 DRUG TOLERANCE DECREASED 201 0.0715
143 HUMAN HERPESVIRUS 6 INFECTION 135 0.0714
144 OCULAR HYPERTENSION 137 0.0705
145 NEPHROTIC SYNDROME 482 0.0702
146 PNEUMONIA FUNGAL 275 0.0696
147 DISSEMINATED INTRAVASCULAR COAGULATION 973 0.0690
148 OESOPHAGEAL CANDIDIASIS 275 0.0689
149 HERPES SIMPLEX 436 0.0670
150 B-CELL LYMPHOMA 224 0.0659
151 PNEUMONIA BACTERIAL 602 0.0655
152 HAEMOLYTIC URAEMIC SYNDROME 150 0.0647
153 ESCHERICHIA SEPSIS 186 0.0641
154 MYCOBACTERIUM AVIUM COMPLEX INFECTION 172 0.0640
155 PERICARDITIS 1059 0.0630
156 ACTINIC KERATOSIS 160 0.0616
157 SYNOVITIS 1110 0.0615
158 STAPHYLOCOCCAL BACTERAEMIA 265 0.0609
159 BREAST CANCER STAGE III 393 0.0606
160 WOUND INFECTION 664 0.0606
161 AUTOIMMUNE DISORDER 590 0.0605
162 FOETAL GROWTH RESTRICTION 364 0.0598
163 LIVE BIRTH 499 0.0596
164 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 295 0.0591
165 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1664 0.0587
166 ESCHERICHIA URINARY TRACT INFECTION 249 0.0585
167 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 154 0.0579
168 BURSITIS 696 0.0573
169 BONE EROSION 198 0.0559
170 COVID-19 PNEUMONIA 661 0.0559
171 ENTEROCOLITIS 322 0.0557
172 LYMPHOPENIA 771 0.0545
173 TUMOUR LYSIS SYNDROME 479 0.0544
174 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 207 0.0541
175 BLOOD IMMUNOGLOBULIN G DECREASED 134 0.0540
176 BRONCHOPNEUMONIA 185 0.0540
177 ENDOCARDITIS 277 0.0540
178 RED BLOOD CELL SEDIMENTATION RATE INCREASED 595 0.0537
179 BRAIN NATRIURETIC PEPTIDE INCREASED 165 0.0535
180 LARGE INTESTINAL ULCER 145 0.0534
181 NECROTISING FASCIITIS 186 0.0527
182 PUSTULAR PSORIASIS 181 0.0526
183 MYOPATHY 455 0.0526
184 BLOOD LACTATE DEHYDROGENASE INCREASED 834 0.0526
185 HEPATOSPLENOMEGALY 135 0.0525
186 LIVER ABSCESS 170 0.0524
187 HYPOALBUMINAEMIA 406 0.0522
188 SEPTIC SHOCK 2269 0.0521
189 CYSTITIS HAEMORRHAGIC 210 0.0520
190 C-REACTIVE PROTEIN INCREASED 1884 0.0517
191 ENCEPHALITIS 358 0.0517
192 ADRENAL INSUFFICIENCY 627 0.0516
193 SQUAMOUS CELL CARCINOMA OF SKIN 310 0.0513
194 BACTERAEMIA 606 0.0510
195 UROSEPSIS 471 0.0510
196 LOWER RESPIRATORY TRACT INFECTION 2314 0.0508
197 JOINT RANGE OF MOTION DECREASED 680 0.0507
198 ACUTE RESPIRATORY DISTRESS SYNDROME 896 0.0506
199 INTERSTITIAL LUNG DISEASE 2439 0.0503
200 LUNG ADENOCARCINOMA 151 0.0501
201 MULTIPLE-DRUG RESISTANCE 153 0.0493
202 ERYSIPELAS 245 0.0487
203 MATERNAL EXPOSURE TIMING UNSPECIFIED 183 0.0487
204 VASCULITIS 562 0.0482
205 FEBRILE NEUTROPENIA 3199 0.0482
206 IMMUNE THROMBOCYTOPENIA 220 0.0480
207 BRONCHIECTASIS 323 0.0479
208 LARGE INTESTINE PERFORATION 332 0.0478
209 SKIN NECROSIS 248 0.0478
210 INFLAMMATORY MARKER INCREASED 236 0.0476
211 TOXIC EPIDERMAL NECROLYSIS 720 0.0474
212 PLEURISY 280 0.0471
213 GRANULOMA 163 0.0470
214 SUBCUTANEOUS ABSCESS 223 0.0465
215 PULMONARY FIBROSIS 889 0.0463
216 HYPERCHOLESTEROLAEMIA 446 0.0461
217 GESTATIONAL DIABETES 220 0.0461
218 AUTOIMMUNE HAEMOLYTIC ANAEMIA 158 0.0461
219 PYELONEPHRITIS 399 0.0460
220 POLYMYALGIA RHEUMATICA 146 0.0459
221 PANCYTOPENIA 2513 0.0449
222 NEPHROPATHY TOXIC 502 0.0447
223 FUNGAL SKIN INFECTION 180 0.0445
224 POLYARTHRITIS 234 0.0443
225 GLOSSODYNIA 993 0.0443
226 LEUKOENCEPHALOPATHY 165 0.0443
227 PROSTATE CANCER METASTATIC 148 0.0443
228 HYDRONEPHROSIS 329 0.0439
229 SYSTEMIC LUPUS ERYTHEMATOSUS 1557 0.0438
230 NEPHRITIS 146 0.0437
231 RHINOVIRUS INFECTION 170 0.0436
232 THERAPY PARTIAL RESPONDER 678 0.0434
233 MYASTHENIA GRAVIS 351 0.0434
234 CHOLANGITIS 268 0.0432
235 OBESITY 682 0.0428
236 PNEUMONIA VIRAL 135 0.0423
237 LUNG INFILTRATION 374 0.0423
238 LIVER INJURY 1035 0.0421
239 LEUKOPENIA 2086 0.0417
240 MYOSITIS 373 0.0415
241 SEPSIS 4631 0.0415
242 PULMONARY ALVEOLAR HAEMORRHAGE 231 0.0411
243 SCIATICA 655 0.0410
244 LOWER LIMB FRACTURE 789 0.0410
245 PARADOXICAL DRUG REACTION 150 0.0407
246 THERAPY NON-RESPONDER 1810 0.0402
247 WOUND DEHISCENCE 136 0.0402
248 RESPIRATORY FAILURE 2933 0.0402
249 DEAFNESS NEUROSENSORY 132 0.0401
250 IMMUNE-MEDIATED ENTEROCOLITIS 147 0.0399
251 MYELODYSPLASTIC SYNDROME 577 0.0399
252 HEPATIC FUNCTION ABNORMAL 1486 0.0398
253 PREMATURE DELIVERY 632 0.0397
254 WOUND 1109 0.0396
255 REBOUND EFFECT 448 0.0396
256 GASTROENTERITIS 575 0.0394
257 IMPAIRED HEALING 1283 0.0390
258 CANDIDA INFECTION 659 0.0390
259 CYTOPENIA 477 0.0389
260 ORAL CANDIDIASIS 509 0.0386
261 CUTANEOUS VASCULITIS 141 0.0386
262 PNEUMOTHORAX 612 0.0386
263 IRRITABLE BOWEL SYNDROME 826 0.0385
264 BONE MARROW FAILURE 782 0.0384
265 BASAL CELL CARCINOMA 591 0.0378
266 MULTI-ORGAN FAILURE 650 0.0376
267 GASTROINTESTINAL PERFORATION 156 0.0375
268 ILEUS PARALYTIC 167 0.0374
269 TUBULOINTERSTITIAL NEPHRITIS 698 0.0372
270 APLASTIC ANAEMIA 193 0.0369
271 SPINAL COMPRESSION FRACTURE 305 0.0369
272 FIBROMYALGIA 895 0.0368
273 ABDOMINAL ABSCESS 162 0.0366
274 LIVER DISORDER 1622 0.0365
275 PREMATURE BABY 1087 0.0361
276 POLYNEUROPATHY 429 0.0358
277 POSTOPERATIVE WOUND INFECTION 240 0.0355
278 PROTEINURIA 672 0.0353
279 HYPERURICAEMIA 145 0.0352
280 SERUM FERRITIN INCREASED 186 0.0352
281 AGRANULOCYTOSIS 653 0.0351
282 IRON DEFICIENCY ANAEMIA 323 0.0350
283 BLEPHAROSPASM 220 0.0349
284 GRIP STRENGTH DECREASED 307 0.0348
285 NECROSIS 194 0.0348
286 ABDOMINAL TENDERNESS 173 0.0348
287 OLIGURIA 215 0.0346
288 SMALL FOR DATES BABY 171 0.0344
289 SHOCK HAEMORRHAGIC 278 0.0341
290 PEMPHIGOID 257 0.0340
291 BACTERIAL INFECTION 635 0.0340
292 DRUG RESISTANCE 874 0.0340
293 SARCOIDOSIS 161 0.0339
294 AUTOIMMUNE HEPATITIS 235 0.0338
295 NORMAL NEWBORN 183 0.0336
296 RENAL IMPAIRMENT 2825 0.0336
297 ENDOPHTHALMITIS 200 0.0333
298 LEFT VENTRICULAR HYPERTROPHY 142 0.0331
299 HAEMOLYTIC ANAEMIA 297 0.0331
300 DRUG ERUPTION 583 0.0329
301 OSTEONECROSIS 1071 0.0326
302 CONCOMITANT DISEASE AGGRAVATED 201 0.0325
303 HYDROCEPHALUS 176 0.0323
304 HERPES VIRUS INFECTION 186 0.0323
305 GAMMA-GLUTAMYLTRANSFERASE INCREASED 715 0.0322
306 GUILLAIN-BARRE SYNDROME 154 0.0318
307 TONSILLITIS 166 0.0318
308 FEBRILE BONE MARROW APLASIA 135 0.0317
309 ANURIA 273 0.0317
310 PURPURA 280 0.0316
311 FEMORAL NECK FRACTURE 162 0.0316
312 CLOSTRIDIUM DIFFICILE COLITIS 334 0.0315
313 PNEUMONITIS 857 0.0314
314 ABSCESS LIMB 134 0.0314
315 RASH VESICULAR 152 0.0314
316 PULMONARY HAEMORRHAGE 245 0.0313
317 HYPERTRIGLYCERIDAEMIA 183 0.0312
318 EXOSTOSIS 285 0.0312
319 DUODENAL ULCER 220 0.0312
320 HYPERCALCAEMIA 384 0.0311
321 CONTRAINDICATED PRODUCT ADMINISTERED 940 0.0310
322 MENINGITIS 207 0.0310
323 PREMATURE LABOUR 175 0.0309
324 DISEASE RECURRENCE 1470 0.0309
325 TYPE 2 DIABETES MELLITUS 1037 0.0308
326 SPLENOMEGALY 360 0.0307
327 CACHEXIA 158 0.0307
328 SECOND PRIMARY MALIGNANCY 254 0.0305
329 STAPHYLOCOCCAL INFECTION 1007 0.0305
330 TENDON RUPTURE 375 0.0303
331 CEREBRAL INFARCTION 741 0.0303
332 ACUTE HEPATIC FAILURE 414 0.0303
333 LUPUS-LIKE SYNDROME 274 0.0302
334 DIARRHOEA HAEMORRHAGIC 282 0.0301
335 PERIPHERAL SENSORY NEUROPATHY 176 0.0301
336 SQUAMOUS CELL CARCINOMA 283 0.0300
337 PRESCRIBED OVERDOSE 581 0.0300
338 OSTEOPOROSIS 1235 0.0300
339 RALES 174 0.0299
340 HYPERGLYCAEMIA 1091 0.0299
341 HAEMATOTOXICITY 284 0.0299
342 NIGHT SWEATS 963 0.0299
343 ANAL ABSCESS 161 0.0298
344 INFLAMMATION 1536 0.0297
345 SUBARACHNOID HAEMORRHAGE 302 0.0296
346 NEPHROGENIC ANAEMIA 137 0.0295
347 LYMPHOMA 457 0.0295
348 ENTERITIS 189 0.0295
349 ILEUS 367 0.0295
350 PRE-ECLAMPSIA 140 0.0294
351 CYTOKINE RELEASE SYNDROME 590 0.0294
352 INTESTINAL PERFORATION 330 0.0294
353 HEPATIC FAILURE 886 0.0294
354 ACUTE MYELOID LEUKAEMIA 458 0.0294
355 METASTASES TO LYMPH NODES 198 0.0293
356 SKIN ULCER 756 0.0292
357 UVEITIS 396 0.0292
358 GENERAL PHYSICAL HEALTH DETERIORATION 3373 0.0291
359 OEDEMA 1571 0.0289
360 COMPRESSION FRACTURE 154 0.0287
361 LEFT VENTRICULAR DYSFUNCTION 192 0.0286
362 RENAL TUBULAR NECROSIS 281 0.0286
363 ALANINE AMINOTRANSFERASE INCREASED 1757 0.0286
364 MUCOSAL INFLAMMATION 749 0.0286
365 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 293 0.0285
366 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 251 0.0284
367 CHOLECYSTITIS ACUTE 160 0.0282
368 DRUG LEVEL INCREASED 467 0.0282
369 CIRCULATORY COLLAPSE 478 0.0280
370 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1538 0.0280
371 JOINT DISLOCATION 296 0.0280
372 PETECHIAE 292 0.0280
373 PATHOGEN RESISTANCE 255 0.0279
374 HAEMOLYSIS 216 0.0279
375 INFUSION RELATED REACTION 1849 0.0279
376 BLOOD ALBUMIN DECREASED 220 0.0277
377 GLUCOSE TOLERANCE IMPAIRED 164 0.0277
378 EOSINOPHILIA 485 0.0276
379 MELAENA 609 0.0276
380 HERPES ZOSTER 1589 0.0276
381 THROMBOCYTOPENIA 3076 0.0275
382 HEPATITIS 701 0.0274
383 LUNG DISORDER 1341 0.0273
384 STREPTOCOCCAL INFECTION 152 0.0273
385 DEVICE RELATED INFECTION 420 0.0273
386 MATERNAL EXPOSURE DURING PREGNANCY 2432 0.0273
387 WHEEZING 1617 0.0272
388 PLEURAL EFFUSION 1659 0.0272
389 HYPOKALAEMIA 1256 0.0272
390 COLITIS ULCERATIVE 1215 0.0272
391 HYPERTRANSAMINASAEMIA 189 0.0271
392 HAEMODIALYSIS 228 0.0271
393 HEPATITIS ACUTE 176 0.0271
394 ULCER HAEMORRHAGE 183 0.0270
395 OSTEONECROSIS OF JAW 668 0.0270
396 RENAL CELL CARCINOMA 132 0.0270
397 TREATMENT FAILURE 2233 0.0269
398 NAIL DISORDER 235 0.0268
399 ABSCESS 428 0.0268
400 GASTRIC ULCER 507 0.0266
401 ACIDOSIS 203 0.0265
402 HYPERBILIRUBINAEMIA 275 0.0265
403 BLOOD CREATININE INCREASED 1731 0.0265
404 PERITONITIS 546 0.0263
405 OSTEOARTHRITIS 1112 0.0262
406 PATHOLOGICAL FRACTURE 133 0.0262
407 DELIRIUM 909 0.0262
408 RENAL CYST 208 0.0262
409 DRUG-INDUCED LIVER INJURY 819 0.0261
410 ASPARTATE AMINOTRANSFERASE INCREASED 1380 0.0260
411 RESPIRATORY TRACT INFECTION 675 0.0259
412 ERYTHEMA MULTIFORME 241 0.0258
413 PNEUMONIA ASPIRATION 640 0.0256
414 INTESTINAL ISCHAEMIA 141 0.0256
415 NEUTROPENIA 3480 0.0256
416 PANCREATITIS ACUTE 575 0.0256
417 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 658 0.0255
418 PRESCRIBED UNDERDOSE 510 0.0255
419 OSTEOMYELITIS 462 0.0255
420 BLISTER 1430 0.0254
421 BLOOD ALKALINE PHOSPHATASE INCREASED 632 0.0254
422 STOMATITIS 1537 0.0253
423 NEUTROPHILIA 144 0.0253
424 ASCITES 741 0.0252
425 SKIN ATROPHY 145 0.0252
426 URINE OUTPUT DECREASED 220 0.0251
427 HIP ARTHROPLASTY 385 0.0251
428 BLOOD UREA INCREASED 419 0.0250
429 TACHYPNOEA 340 0.0250
430 LEUKOCYTOSIS 452 0.0250
431 VENTRICULAR SEPTAL DEFECT 143 0.0249
432 TRANSAMINASES INCREASED 552 0.0248
433 PYREXIA 8579 0.0248
434 ELECTROLYTE IMBALANCE 288 0.0248
435 PSORIATIC ARTHROPATHY 1004 0.0247
436 CARDIAC FAILURE ACUTE 164 0.0246
437 INFECTION 3551 0.0245
438 DISEASE PROGRESSION 2897 0.0245
439 RETINAL HAEMORRHAGE 174 0.0244
440 ATELECTASIS 236 0.0244
441 MOUTH ULCERATION 514 0.0244
442 APHTHOUS ULCER 189 0.0243
443 RETINAL DETACHMENT 224 0.0243
444 LYMPHADENOPATHY 861 0.0243
445 COLITIS 917 0.0242
446 PULMONARY TOXICITY 171 0.0242
447 HEPATIC ENCEPHALOPATHY 225 0.0241
448 HYPERKALAEMIA 838 0.0239
449 FOOT DEFORMITY 263 0.0237
450 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 184 0.0237
451 HAEMATURIA 807 0.0235
452 RHEUMATOID ARTHRITIS 2669 0.0235
453 BREAST CANCER STAGE II 195 0.0234
454 BRAIN OEDEMA 294 0.0233
455 SKIN INFECTION 260 0.0232
456 LYMPHOCYTE COUNT DECREASED 409 0.0231
457 MYOCARDIAL ISCHAEMIA 263 0.0231
458 CELLULITIS 1164 0.0231
459 RHINITIS 186 0.0230
460 TRICUSPID VALVE INCOMPETENCE 183 0.0230
461 RESPIRATORY SYNCYTIAL VIRUS INFECTION 200 0.0229
462 MYOCARDITIS 262 0.0228
463 EXPOSURE DURING PREGNANCY 1413 0.0227
464 NEUTROPHIL COUNT DECREASED 922 0.0226
465 JAUNDICE 608 0.0226
466 HEPATOTOXICITY 503 0.0226
467 HEPATOMEGALY 222 0.0226
468 HYPONATRAEMIA 1269 0.0225
469 LIVER FUNCTION TEST ABNORMAL 655 0.0225
470 IMMUNODEFICIENCY 335 0.0225
471 SKIN MASS 150 0.0224
472 CARDIOMEGALY 276 0.0224
473 HEPATIC ENZYME INCREASED 1527 0.0224
474 JOINT EFFUSION 154 0.0223
475 EOSINOPHIL COUNT INCREASED 186 0.0223
476 WALKING AID USER 147 0.0223
477 ACUTE RESPIRATORY FAILURE 428 0.0222
478 HEMIPARESIS 376 0.0222
479 RESPIRATORY DISTRESS 612 0.0222
480 PLATELET COUNT INCREASED 289 0.0221
481 ALTERED STATE OF CONSCIOUSNESS 477 0.0220
482 PNEUMONIA 7120 0.0220
483 THERAPEUTIC PRODUCT EFFECT DECREASED 983 0.0219
484 OSTEOPENIA 332 0.0219
485 DRUG INTOLERANCE 2106 0.0218
486 NEUROTOXICITY 382 0.0218
487 TYPE 1 DIABETES MELLITUS 131 0.0217
488 CHOLESTASIS 417 0.0217
489 ULCER 345 0.0217
490 NEUTROPHIL COUNT INCREASED 222 0.0217
491 GASTRITIS 570 0.0216
492 WHITE BLOOD CELL COUNT INCREASED 829 0.0216
493 INTRAOCULAR PRESSURE INCREASED 276 0.0216
494 OBSTRUCTIVE AIRWAYS DISORDER 240 0.0216
495 GAIT INABILITY 721 0.0216
496 ANAEMIA 4091 0.0214
497 ARTHROPATHY 1191 0.0214
498 HEPATIC STEATOSIS 399 0.0214
499 RASH PUSTULAR 156 0.0214
500 MITRAL VALVE INCOMPETENCE 241 0.0213
501 SHOCK 489 0.0212
502 GENERALISED OEDEMA 263 0.0212
503 DERMATITIS BULLOUS 153 0.0211
504 PROSTATIC SPECIFIC ANTIGEN INCREASED 291 0.0211
505 HYPOPHOSPHATAEMIA 156 0.0211
506 HYPERTHERMIA 161 0.0211
507 CORONAVIRUS INFECTION 139 0.0210
508 HYPOXIA 740 0.0210
509 MUSCULOSKELETAL PAIN 1100 0.0210
510 DRUG INTERACTION 3330 0.0210
511 STEVENS-JOHNSON SYNDROME 466 0.0209
512 LUNG INFECTION 325 0.0209
513 ACUTE KIDNEY INJURY 3200 0.0209
514 POLYURIA 171 0.0209
515 CARDIAC FAILURE 1675 0.0208
516 BLOOD CHOLESTEROL INCREASED 971 0.0208
517 MATERNAL EXPOSURE BEFORE PREGNANCY 142 0.0208
518 RASH MACULO-PAPULAR 461 0.0207
519 TENDONITIS 320 0.0206
520 PRODUCT USE IN UNAPPROVED INDICATION 5117 0.0206
521 SKIN LESION 565 0.0206
522 BLOOD BILIRUBIN INCREASED 554 0.0205
523 RESPIRATORY DISORDER 613 0.0205
524 HAEMODYNAMIC INSTABILITY 155 0.0203
525 CHOLECYSTITIS 242 0.0203
526 MALNUTRITION 227 0.0203
527 CONDITION AGGRAVATED 6162 0.0202
528 COAGULOPATHY 335 0.0201
529 METASTASES TO LUNG 232 0.0201
530 HYPERLIPIDAEMIA 238 0.0199
531 UPPER GASTROINTESTINAL HAEMORRHAGE 335 0.0199
532 SPINAL PAIN 232 0.0198
533 PLATELET COUNT DECREASED 2102 0.0197
534 COLITIS ISCHAEMIC 133 0.0197
535 HEPATIC CIRRHOSIS 367 0.0195
536 RENAL FAILURE CHRONIC 149 0.0194
537 GROIN PAIN 170 0.0193
538 FACIAL PARALYSIS 164 0.0192
539 DISCOMFORT 1171 0.0192
540 FOETAL EXPOSURE DURING PREGNANCY 1560 0.0192
541 PAPULE 135 0.0191
542 RIGHT VENTRICULAR FAILURE 134 0.0191
543 PHARYNGITIS 234 0.0188
544 PREGNANCY 376 0.0188
545 OFF LABEL USE 16112 0.0184
546 EMPHYSEMA 185 0.0183
547 DIABETES MELLITUS 1394 0.0183
548 AORTIC ANEURYSM 139 0.0183
549 GASTROINTESTINAL INFECTION 163 0.0182
550 PSYCHIATRIC SYMPTOM 134 0.0181
551 SENSATION OF FOREIGN BODY 153 0.0181
552 DYSPNOEA EXERTIONAL 682 0.0181
553 TOXIC SKIN ERUPTION 182 0.0181
554 PERICARDIAL EFFUSION 417 0.0180
555 ABORTION INDUCED 169 0.0179
556 HYPOMAGNESAEMIA 249 0.0179
557 MYELOSUPPRESSION 644 0.0179
558 HYPOCALCAEMIA 337 0.0178
559 PULMONARY EMBOLISM 1687 0.0177
560 FUNGAL INFECTION 590 0.0177
561 COVID-19 3088 0.0176
562 CARDIOMYOPATHY 260 0.0176
563 RENAL FAILURE ACUTE 746 0.0176
564 PULMONARY MASS 260 0.0174
565 HEMIPLEGIA 145 0.0174
566 HAEMATOMA 451 0.0174
567 OESOPHAGITIS 190 0.0174
568 INTENTIONAL PRODUCT USE ISSUE 1522 0.0174
569 FACIAL PAIN 155 0.0173
570 ARTERIOSCLEROSIS 163 0.0173
571 PULMONARY CONGESTION 228 0.0173
572 TENDERNESS 179 0.0172
573 END STAGE RENAL DISEASE 313 0.0171
574 MOBILITY DECREASED 1232 0.0171
575 HAEMATEMESIS 434 0.0171
576 TACHYCARDIA 1521 0.0171
577 BODY TEMPERATURE INCREASED 349 0.0171
578 METABOLIC ACIDOSIS 547 0.0171
579 METASTASES TO LIVER 300 0.0171
580 ACUTE CORONARY SYNDROME 141 0.0170
581 ORAL HERPES 332 0.0170
582 CAESAREAN SECTION 198 0.0170
583 BRONCHOSPASM 242 0.0169
584 DECUBITUS ULCER 138 0.0169
585 URINARY TRACT INFECTION 2886 0.0169
586 ENCEPHALOPATHY 415 0.0169
587 PULMONARY HYPERTENSION 351 0.0168
588 JOINT SWELLING 2031 0.0168
589 ASTHMA 1901 0.0168
590 EPILEPSY 511 0.0167
591 OEDEMA PERIPHERAL 2034 0.0167
592 TASTE DISORDER 337 0.0166
593 DEEP VEIN THROMBOSIS 1075 0.0165
594 HAEMOPTYSIS 461 0.0165
595 EYE INFLAMMATION 157 0.0164
596 VENTRICULAR TACHYCARDIA 271 0.0164
597 GASTROINTESTINAL DISORDER 1467 0.0164
598 HYPERTHYROIDISM 237 0.0164
599 GLAUCOMA 314 0.0163
600 KNEE ARTHROPLASTY 342 0.0162
601 CARDIOTOXICITY 144 0.0161
602 OPTIC NEURITIS 146 0.0161
603 CEREBRAL HAEMORRHAGE 573 0.0160
604 CATARACT 953 0.0160
605 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 274 0.0160
606 ACUTE MYOCARDIAL INFARCTION 471 0.0160
607 NEPHROPATHY 148 0.0158
608 CLOSTRIDIUM DIFFICILE INFECTION 346 0.0158
609 HYPERTENSIVE CRISIS 176 0.0158
610 EAR PAIN 307 0.0158
611 GENERALISED TONIC-CLONIC SEIZURE 261 0.0158
612 LIP SWELLING 524 0.0157
613 EMBOLISM 130 0.0156
614 SPINAL OSTEOARTHRITIS 137 0.0156
615 SUDDEN DEATH 165 0.0156
616 LIVER FUNCTION TEST INCREASED 334 0.0155
617 SWELLING 1453 0.0155
618 SINUS TACHYCARDIA 220 0.0155
619 IMMUNE SYSTEM DISORDER 204 0.0155
620 DERMATITIS ALLERGIC 194 0.0154
621 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1097 0.0154
622 FACE OEDEMA 260 0.0154
623 ROAD TRAFFIC ACCIDENT 644 0.0154
624 ANGIOEDEMA 680 0.0154
625 DRUG LEVEL DECREASED 155 0.0152
626 PRODUCTIVE COUGH 726 0.0152
627 SPINAL FRACTURE 304 0.0152
628 MUSCLE ATROPHY 191 0.0151
629 FISTULA 169 0.0150
630 HYPERTENSION 3181 0.0150
631 UPPER RESPIRATORY TRACT INFECTION 693 0.0150
632 HEPATITIS C 181 0.0150
633 DIVERTICULITIS 414 0.0149
634 ANAPHYLACTIC REACTION 822 0.0149
635 RENAL FAILURE 1972 0.0148
636 NO THERAPEUTIC RESPONSE 181 0.0148
637 CYANOSIS 233 0.0148
638 ABDOMINAL PAIN 3446 0.0148
639 APPENDICITIS 138 0.0148
640 CARDIOGENIC SHOCK 210 0.0146
641 HYPOTHYROIDISM 467 0.0146
642 HAEMOGLOBIN DECREASED 1501 0.0146
643 RECTAL HAEMORRHAGE 628 0.0146
644 CONJUNCTIVITIS 271 0.0146
645 ATRIAL FIBRILLATION 1420 0.0146
646 NODULE 190 0.0145
647 CONTUSION 1399 0.0145
648 METASTASES TO BONE 238 0.0145
649 MUSCULAR WEAKNESS 1642 0.0144
650 THERAPEUTIC RESPONSE DECREASED 876 0.0144
651 STATUS EPILEPTICUS 163 0.0144
652 GLOMERULAR FILTRATION RATE DECREASED 177 0.0144
653 ATAXIA 170 0.0143
654 HAEMATOCHEZIA 790 0.0143
655 GASTROINTESTINAL HAEMORRHAGE 1191 0.0142
656 CONFUSIONAL STATE 2303 0.0142
657 VIRAL INFECTION 474 0.0142
658 MUSCULOSKELETAL STIFFNESS 1239 0.0141
659 PALLOR 381 0.0140
660 SLEEP DISORDER 983 0.0139
661 PSYCHOTIC DISORDER 410 0.0139
662 DECREASED IMMUNE RESPONSIVENESS 136 0.0138
663 FREQUENT BOWEL MOVEMENTS 374 0.0138
664 DEPRESSED LEVEL OF CONSCIOUSNESS 545 0.0138
665 BEDRIDDEN 181 0.0138
666 ILL-DEFINED DISORDER 831 0.0137
667 EYELID PTOSIS 139 0.0137
668 COLON CANCER 202 0.0135
669 HEPATOCELLULAR INJURY 192 0.0135
670 URINARY RETENTION 450 0.0135
671 MANIA 220 0.0134
672 PHOTOPHOBIA 251 0.0133
673 SECRETION DISCHARGE 167 0.0133
674 DIPLOPIA 345 0.0133
675 ANOREXIA 171 0.0133
676 HAEMATOCRIT DECREASED 263 0.0132
677 PULMONARY OEDEMA 592 0.0132
678 SWELLING FACE 860 0.0132
679 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 688 0.0132
680 CORONARY ARTERY DISEASE 398 0.0131
681 PHOTOSENSITIVITY REACTION 217 0.0131
682 MASS 183 0.0131
683 INJURY 919 0.0131
684 DRY MOUTH 1058 0.0130
685 WHITE BLOOD CELL COUNT DECREASED 1413 0.0130
686 MEDICATION ERROR 722 0.0130
687 VISUAL ACUITY REDUCED 431 0.0130
688 FEMUR FRACTURE 401 0.0129
689 DECREASED APPETITE 2986 0.0128
690 SWOLLEN TONGUE 401 0.0128
691 DYSPNOEA 7215 0.0127
692 HIATUS HERNIA 165 0.0127
693 METASTASES TO CENTRAL NERVOUS SYSTEM 164 0.0127
694 ANGINA PECTORIS 364 0.0127
695 PANCREATITIS 670 0.0127
696 NEUROPATHY PERIPHERAL 1205 0.0127
697 MALIGNANT MELANOMA 169 0.0126
698 SMALL INTESTINAL OBSTRUCTION 155 0.0126
699 CHEST PAIN 2311 0.0125
700 VENTRICULAR FIBRILLATION 138 0.0124
701 DYSURIA 455 0.0123
702 BONE DISORDER 224 0.0123
703 FOOT FRACTURE 233 0.0123
704 PERIPHERAL SWELLING 1890 0.0123
705 SKIN REACTION 170 0.0121
706 SINUSITIS 1236 0.0120
707 BLOOD POTASSIUM INCREASED 195 0.0120
708 ASPIRATION 131 0.0119
709 MALIGNANT NEOPLASM PROGRESSION 1224 0.0119
710 ARTHRITIS 939 0.0119
711 GOUT 214 0.0119
712 ARRHYTHMIA 559 0.0118
713 ISCHAEMIC STROKE 210 0.0118
714 NEOPLASM PROGRESSION 409 0.0117
715 OXYGEN SATURATION DECREASED 657 0.0117
716 EJECTION FRACTION DECREASED 180 0.0116
717 NEOPLASM 133 0.0116
718 LETHARGY 665 0.0115
719 RENAL DISORDER 538 0.0115
720 BLOOD CREATINE PHOSPHOKINASE INCREASED 332 0.0115
721 EYE PAIN 650 0.0115
722 RHABDOMYOLYSIS 480 0.0115
723 SKIN DISORDER 383 0.0115
724 ANAPHYLACTIC SHOCK 292 0.0113
725 CENTRAL NERVOUS SYSTEM LESION 155 0.0113
726 DERMATITIS 235 0.0112
727 DYSARTHRIA 421 0.0112
728 VOMITING 5254 0.0112
729 CARDIAC ARREST 918 0.0111
730 INTERNATIONAL NORMALISED RATIO INCREASED 317 0.0111
731 DIABETIC KETOACIDOSIS 267 0.0111
732 BLINDNESS UNILATERAL 156 0.0110
733 FRACTURE 209 0.0110
734 RIB FRACTURE 227 0.0110
735 BRONCHITIS 814 0.0110
736 HYPERSENSITIVITY 2037 0.0110
737 ORTHOSTATIC HYPOTENSION 190 0.0109
738 HYPOAESTHESIA 1633 0.0109
739 HYPOPHAGIA 278 0.0109
740 BLINDNESS 443 0.0109
741 SUBDURAL HAEMATOMA 155 0.0108
742 SENSORY DISTURBANCE 173 0.0108
743 TOXICITY TO VARIOUS AGENTS 1809 0.0107
744 CARDIOVASCULAR DISORDER 271 0.0107
745 DIARRHOEA 6885 0.0107
746 CARDIO-RESPIRATORY ARREST 444 0.0106
747 INTERVERTEBRAL DISC PROTRUSION 232 0.0106
748 COUGH 2976 0.0106
749 DISORIENTATION 419 0.0106
750 ARTHRALGIA 4378 0.0105
751 CHOLELITHIASIS 344 0.0105
752 RASH PRURITIC 566 0.0104
753 URTICARIA 1747 0.0104
754 DIABETES MELLITUS INADEQUATE CONTROL 183 0.0103
755 RASH 4492 0.0103
756 HAEMORRHAGE INTRACRANIAL 154 0.0103
757 HALLUCINATION, VISUAL 217 0.0103
758 ALOPECIA 2012 0.0102
759 NASOPHARYNGITIS 1886 0.0102
760 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 491 0.0102
761 DISABILITY 202 0.0102
762 ORAL PAIN 228 0.0102
763 CHILLS 1191 0.0101
764 SYNCOPE 1016 0.0101
765 HAEMORRHOIDS 196 0.0100
766 APHASIA 303 0.0100
767 CYSTITIS 318 0.0100
768 NERVOUS SYSTEM DISORDER 311 0.0100
769 DRUG INEFFECTIVE 13097 0.0099
770 ABDOMINAL PAIN UPPER 2044 0.0099
771 DYSPHAGIA 942 0.0099
772 BLOOD POTASSIUM DECREASED 298 0.0099
773 HYPOGLYCAEMIA 479 0.0099
774 ABORTION SPONTANEOUS 395 0.0098
775 MALAISE 4319 0.0098
776 JOINT STIFFNESS 258 0.0098
777 BLOOD SODIUM DECREASED 185 0.0098
778 EAR INFECTION 261 0.0098
779 PRODUCT USE ISSUE 1836 0.0098
780 TRANSIENT ISCHAEMIC ATTACK 328 0.0097
781 HYPOKINESIA 141 0.0097
782 CHRONIC KIDNEY DISEASE 736 0.0097
783 FLUID RETENTION 490 0.0096
784 AMNESIA 623 0.0096
785 ERYTHEMA 1968 0.0096
786 RED BLOOD CELL COUNT DECREASED 273 0.0095
787 ABDOMINAL PAIN LOWER 241 0.0095
788 URINARY INCONTINENCE 282 0.0095
789 PARALYSIS 136 0.0095
790 PRODUCT PRESCRIBING ERROR 226 0.0095
791 INFLUENZA 1051 0.0094
792 PARAESTHESIA 1480 0.0094
793 RESTLESSNESS 344 0.0094
794 DEHYDRATION 1249 0.0094
795 HYPOTENSION 1876 0.0093
796 RASH GENERALISED 242 0.0093
797 WEIGHT INCREASED 2084 0.0093
798 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 272 0.0093
799 COMA 440 0.0092
800 RASH ERYTHEMATOUS 441 0.0092
801 BRADYCARDIA 486 0.0092
802 ABDOMINAL DISCOMFORT 1534 0.0091
803 COGNITIVE DISORDER 427 0.0091
804 PULMONARY ARTERIAL HYPERTENSION 132 0.0091
805 NEURALGIA 221 0.0091
806 LACTIC ACIDOSIS 292 0.0090
807 DRUG EXPOSURE DURING PREGNANCY 305 0.0090
808 TINNITUS 409 0.0089
809 MUSCULOSKELETAL CHEST PAIN 137 0.0088
810 BONE PAIN 510 0.0087
811 POST PROCEDURAL COMPLICATION 167 0.0087
812 MYALGIA 1461 0.0086
813 BLOOD PRESSURE DECREASED 570 0.0086
814 WEIGHT DECREASED 2393 0.0086
815 TREATMENT NONCOMPLIANCE 466 0.0085
816 CHEST DISCOMFORT 872 0.0085
817 DYSPEPSIA 837 0.0085
818 PRODUCT PRESCRIBING ISSUE 185 0.0085
819 PLASMA CELL MYELOMA 330 0.0084
820 THIRST 151 0.0084
821 LABORATORY TEST ABNORMAL 249 0.0084
822 PAIN IN JAW 237 0.0084
823 DEAFNESS 218 0.0083
824 VISUAL IMPAIRMENT 1029 0.0083
825 CHROMATURIA 186 0.0082
826 ASTHENIA 3098 0.0082
827 PAIN IN EXTREMITY 2414 0.0082
828 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 138 0.0081
829 RASH PAPULAR 182 0.0081
830 SLEEP APNOEA SYNDROME 154 0.0081
831 INTESTINAL OBSTRUCTION 304 0.0081
832 GASTROOESOPHAGEAL REFLUX DISEASE 649 0.0081
833 FEELING HOT 493 0.0080
834 HALLUCINATION 601 0.0080
835 FEELING COLD 222 0.0080
836 COLD SWEAT 140 0.0079
837 BACK PAIN 1827 0.0079
838 PRESYNCOPE 190 0.0078
839 KIDNEY INFECTION 153 0.0078
840 SKIN CANCER 167 0.0077
841 DEPRESSED MOOD 410 0.0077
842 FAECES DISCOLOURED 168 0.0077
843 HAEMORRHAGE 810 0.0077
844 ECZEMA 405 0.0077
845 THROMBOSIS 619 0.0077
846 GAIT DISTURBANCE 1469 0.0077
847 NECK PAIN 424 0.0076
848 PALPITATIONS 887 0.0076
849 EPISTAXIS 565 0.0075
850 HEADACHE 4731 0.0075
851 DYSPHONIA 440 0.0075
852 LOSS OF CONSCIOUSNESS 958 0.0075
853 OROPHARYNGEAL PAIN 681 0.0073
854 MIGRAINE 702 0.0073
855 MUSCLE SPASMS 1349 0.0073
856 RASH MACULAR 257 0.0073
857 TOOTHACHE 133 0.0073
858 ADVERSE DRUG REACTION 649 0.0072
859 VERTIGO 438 0.0072
860 EYE DISORDER 236 0.0072
861 NAUSEA 5642 0.0071
862 DEPRESSION 1617 0.0071
863 PRURITUS 2717 0.0071
864 INSOMNIA 1873 0.0070
865 FALL 2337 0.0070
866 CONSTIPATION 1529 0.0070
867 LUNG NEOPLASM MALIGNANT 286 0.0070
868 LOCALISED INFECTION 168 0.0069
869 BLOOD PRESSURE SYSTOLIC INCREASED 135 0.0069
870 CONVULSION 395 0.0069
871 DYSSTASIA 201 0.0069
872 EYE SWELLING 256 0.0069
873 VISION BLURRED 944 0.0069
874 MOOD SWINGS 219 0.0069
875 HYPERHIDROSIS 885 0.0069
876 ABDOMINAL DISTENSION 715 0.0068
877 DIZZINESS 3416 0.0068
878 MEMORY IMPAIRMENT 940 0.0068
879 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 159 0.0068
880 ADVERSE EVENT 627 0.0068
881 FATIGUE 5281 0.0068
882 SPEECH DISORDER 354 0.0067
883 SEIZURE 779 0.0067
884 MENTAL DISORDER 293 0.0067
885 TREMOR 1087 0.0065
886 PAIN 3997 0.0065
887 DRY EYE 324 0.0065
888 DISTURBANCE IN ATTENTION 350 0.0065
889 AGITATION 472 0.0064
890 DRUG EFFECT INCOMPLETE 233 0.0064
891 EATING DISORDER 135 0.0063
892 MENTAL STATUS CHANGES 174 0.0063
893 GASTRIC CANCER 157 0.0062
894 LACRIMATION INCREASED 187 0.0062
895 RESPIRATORY ARREST 170 0.0062
896 HIP FRACTURE 196 0.0061
897 POOR QUALITY SLEEP 131 0.0061
898 ELECTROCARDIOGRAM QT PROLONGED 217 0.0060
899 MOVEMENT DISORDER 193 0.0060
900 PAIN OF SKIN 160 0.0059
901 SKIN EXFOLIATION 500 0.0059
902 BLOOD PRESSURE INCREASED 902 0.0059
903 POLLAKIURIA 245 0.0059
904 BLOOD PRESSURE FLUCTUATION 141 0.0059
905 DEMENTIA 164 0.0059
906 MUSCLE TWITCHING 135 0.0059
907 LIMB DISCOMFORT 180 0.0058
908 RENAL INJURY 172 0.0058
909 SKIN DISCOLOURATION 266 0.0058
910 ABNORMAL BEHAVIOUR 229 0.0058
911 OCULAR HYPERAEMIA 274 0.0058
912 THROAT TIGHTNESS 155 0.0057
913 AGGRESSION 286 0.0057
914 ANXIETY 1626 0.0057
915 NEPHROLITHIASIS 259 0.0056
916 CARDIAC DISORDER 522 0.0056
917 MYOCARDIAL INFARCTION 968 0.0055
918 ABASIA 137 0.0055
919 CARDIAC FAILURE CONGESTIVE 444 0.0055
920 SOMNOLENCE 1108 0.0055
921 HEART RATE INCREASED 535 0.0054
922 ACCIDENTAL OVERDOSE 196 0.0054
923 UNRESPONSIVE TO STIMULI 138 0.0053
924 RHINORRHOEA 335 0.0052
925 LIMB INJURY 140 0.0051
926 EYE IRRITATION 295 0.0051
927 NEOPLASM MALIGNANT 339 0.0051
928 MOOD ALTERED 138 0.0051
929 BALANCE DISORDER 436 0.0050
930 EYE PRURITUS 166 0.0049
931 SUICIDAL IDEATION 449 0.0049
932 UNDERDOSE 357 0.0049
933 NASAL CONGESTION 283 0.0048
934 INFLUENZA LIKE ILLNESS 394 0.0048
935 NIGHTMARE 164 0.0047
936 IRRITABILITY 281 0.0047
937 INTENTIONAL PRODUCT MISUSE 408 0.0047
938 CRYING 166 0.0046
939 GASTRIC DISORDER 152 0.0044
940 DEATH 3785 0.0044
941 HEAD INJURY 137 0.0043
942 PSORIASIS 551 0.0042
943 FLATULENCE 237 0.0042
944 PROSTATE CANCER 334 0.0041
945 ANGER 140 0.0041
946 HYPOACUSIS 178 0.0041
947 CEREBROVASCULAR ACCIDENT 695 0.0041
948 PANIC ATTACK 149 0.0041
949 DYSKINESIA 166 0.0041
950 HEART RATE DECREASED 143 0.0041
951 WITHDRAWAL SYNDROME 171 0.0041
952 FLUSHING 409 0.0040
953 BURNING SENSATION 279 0.0040
954 HOT FLUSH 299 0.0040
955 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 713 0.0040
956 DYSGEUSIA 280 0.0038
957 THROAT IRRITATION 159 0.0035
958 BLOOD GLUCOSE INCREASED 656 0.0035
959 SUICIDE ATTEMPT 210 0.0035
960 HOSPITALISATION 526 0.0034
961 BREAST CANCER 319 0.0034
962 SURGERY 199 0.0034
963 DRY SKIN 423 0.0032
964 DRUG EFFECT DECREASED 170 0.0032
965 FEELING ABNORMAL 735 0.0031
966 ILLNESS 310 0.0030
967 UNEVALUABLE EVENT 217 0.0029
968 ACNE 217 0.0029
969 DERMATITIS ATOPIC 146 0.0028
970 NO ADVERSE EVENT 473 0.0026
971 INJECTION SITE REACTION 178 0.0026
972 EMOTIONAL DISTRESS 311 0.0026
973 OVERDOSE 550 0.0025
974 THERAPY INTERRUPTED 182 0.0025
975 INTENTIONAL OVERDOSE 161 0.0025
976 DRUG ABUSE 193 0.0023
977 BLADDER CANCER 130 0.0022
978 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 156 0.0022
979 MULTIPLE SCLEROSIS RELAPSE 149 0.0022
980 PRODUCT QUALITY ISSUE 291 0.0021
981 SKIN BURNING SENSATION 139 0.0019
982 PRODUCT DOSE OMISSION ISSUE 557 0.0019
983 INCORRECT DOSE ADMINISTERED 377 0.0016
984 INJECTION SITE ERYTHEMA 197 0.0016
985 DRUG DEPENDENCE 237 0.0015
986 INJECTION SITE PAIN 331 0.0011
987 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 198 0.0010
988 DRUG DOSE OMISSION 134 0.0008